A similar shift in KP metabolism has been presented by Darlington et al.37, who described a decrease in the ratio of plasma 3-HAA/AA in a variety of neurological and diverse inflammatory disorders, including Huntingtons disease, chronic brain injury, stroke, osteoporosis and depression. The gene discussed is NPPA; the disease is depressive symptom measurement.